LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price was down 19.2% on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares were traded during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The company has a fifty day moving average price of C$0.11 and a two-hundred day moving average price of C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Read More
- Five stocks we like better than LexaGene
- What Does Downgrade Mean in Investing?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How to Use the MarketBeat Stock Screener
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Invest in the FAANG Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
